Brokers Set Expectations for Ayr Wellness FY2024 Earnings

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Analysts at Atb Cap Markets dropped their FY2024 EPS estimates for Ayr Wellness in a report released on Wednesday, November 13th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings of ($1.34) per share for the year, down from their previous estimate of ($1.15). Atb Cap Markets has a “Strong Sell” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Atb Cap Markets also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.29) EPS and FY2025 earnings at ($0.98) EPS.

Other equities analysts have also issued research reports about the stock. Roth Mkm reduced their price target on shares of Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a research report on Thursday, November 14th. Roth Capital upgraded Ayr Wellness to a “strong-buy” rating in a research note on Friday, November 8th.

Ayr Wellness Price Performance

Shares of OTCMKTS AYRWF opened at $0.72 on Monday. The company has a market capitalization of $82.19 million, a PE ratio of -0.32 and a beta of 2.00. The company has a quick ratio of 0.58, a current ratio of 1.59 and a debt-to-equity ratio of 0.76. The stock’s 50 day moving average price is $1.77 and its 200-day moving average price is $1.96. Ayr Wellness has a twelve month low of $0.71 and a twelve month high of $4.09.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.